L735,524 - THE RATIONAL DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR

被引：0

作者：

DORSEY, BD

LEVIN, RB

MCDANIEL, SL

VACCA, JP

DARKE, PL

ZUGAY, JA

EMINI, EA

SCHLEIF, WA

QUINTERO, JC

LIN, JH

CHEN, IW

OSTOVIC, D

FITZGERALD, PMD

HOLLOWAY, MK

ANDERSON, PS

HUFF, JR

机构：

[1] MERCK SHARP & DOHME LTD,DEPT MED CHEM,W POINT,PA 19486

[2] MERCK SHARP & DOHME LTD,DEPT MOLEC BIOL,W POINT,PA 19486

[3] MERCK SHARP & DOHME LTD,DEPT VIRUS & CELL BIOL,W POINT,PA 19486

[4] MERCK SHARP & DOHME LTD,DEPT DRUG METAB,W POINT,PA 19486

[5] MERCK SHARP & DOHME LTD,DEPT PHARMACEUT RES,W POINT,PA 19486

[6] MERCK SHARP & DOHME LTD,DEPT BIOPHYS CHEM,W POINT,PA 19486

[7] MERCK SHARP & DOHME LTD,DEPT MOLEC SYST,W POINT,PA 19486

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1993年 / 206卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：6 / MEDI

共 50 条

[1] L-735,524 - THE DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR
DORSEY, BD
LEVIN, RB
MCDANIEL, SL
VACCA, JP
GUARE, JP
DARKE, PL
ZUGAY, JA
EMINI, EA
SCHLEIF, WA
QUINTERO, JC
LIN, JH
CHEN, IW
HOLLOWAY, MK
FITZGERALD, PMD
AXEL, MG
OSTOVIC, D
ANDERSON, PS
HUFF, JR
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) : 3443 - 3451
[2] PHARMACOKINETICS OF L-735,524, AN HIV PROTEASE INHIBITOR
TEPPLER, H
OSBORNE, B
BJORNSSON, TD
POMERANTZ, R
WOOLF, E
YEH, K
DEUTSCH, P
SQUIRES, K
SAAG, M
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 195 - 195
[3] L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
VACCA, JP
DORSEY, BD
SCHLEIF, WA
LEVIN, RB
MCDANIEL, SL
DARKE, PL
ZUGAY, J
QUINTERO, JC
BLAHY, OM
ROTH, E
SARDANA, VV
SCHLABACH, AJ
GRAHAM, PI
CONDRA, JH
GOTLIB, L
HOLLOWAY, MK
LIN, J
CHEN, IW
VASTAG, K
OSTOVIC, D
ANDERSON, PS
EMINI, EA
HUFF, JR
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4096 - 4100
[4] METABOLITES OF L-735,524, A POTENT HIV-1 PROTEASE INHIBITOR, IN HUMAN URINE
BALANI, SK
ARISON, BH
MATHAI, L
KAUFFMAN, LR
MILLER, RR
STEARNS, RA
CHEN, IW
LIN, JH
DRUG METABOLISM AND DISPOSITION, 1995, 23 (02) : 266 - 270
[5] PH-DEPENDENT ORAL ABSORPTION OF L-735,524, A POTENT HIV PROTEASE INHIBITOR, IN RATS AND DOGS
LIN, JH
CHEN, IW
VASTAG, KJ
OSTOVIC, D
DRUG METABOLISM AND DISPOSITION, 1995, 23 (07) : 730 - 735
[6] CRYSTAL-STRUCTURE AT 1.9-ANGSTROM RESOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES
CHEN, ZG
LI, Y
CHEN, E
HALL, DL
DARKE, PL
CULBERSON, C
SHAFER, JA
KUO, LC
JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (42) : 26344 - 26348
[7] REGIOSPECIFIC INTESTINAL-ABSORPTION OF THE HIV PROTEASE INHIBITOR L-735,524 IN BEAGLE DOGS
KWEI, GY
NOVAK, LB
HETTRICK, LA
REISS, ER
OSTOVIC, D
LOPER, AE
LUI, CY
HIGGINS, RJ
CHEN, IW
LIN, JH
PHARMACEUTICAL RESEARCH, 1995, 12 (06) : 884 - 888
[8] SYNTHESIS AND EVALUATION OF PYRIDYL ANALOGS OF L-735,524 - POTENT HIV-1 PROTEASE INHIBITORS
DORSEY, BD
MCDANIEL, SL
LEVIN, RB
VACCA, JP
DARKE, PL
ZUGAY, JA
EMINI, EA
SCHLEIF, WA
LIN, JH
CHEN, IW
HOLLOWAY, MK
ANDERSON, PS
HUFF, JR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (23) : 2769 - 2774
[9] DESIGN AND SYNTHESIS OF POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS
KALDOR, SW
KALISH, V
DRESSMAN, BA
FRITZ, JE
HAMMOND, M
CROWELL, TA
TATLOCK, J
REICH, S
DAVIES, J
APPELT, K
SHETTY, B
SU, KS
CAMPANALE, KM
BURGESS, JA
LUBBENHUSEN, PP
BAXTER, AJ
MUESING, MA
HATCH, SD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 17 - MEDI
[10] RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
LAM, PYS
JADHAV, PK
EYERMANN, CJ
HODGE, CN
RU, Y
BACHELER, LT
MEEK, JL
OTTO, MJ
RAYNER, MM
WONG, YN
CHANG, CH
WEBER, PC
JACKSON, DA
SHARPE, TR
ERICKSONVIITANEN, S
SCIENCE, 1994, 263 (5145) : 380 - 384

← 1 2 3 4 5 →